Your browser doesn't support javascript.
loading
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.
Alghamdi, Jahad; Alaamery, Manal; Barhoumi, Tlili; Rashid, Mamoon; Alajmi, Hala; Aljasser, Nasser; Alhendi, Yaseen; Alkhalaf, Hind; Alqahtani, Hanadi; Algablan, Omer; Alshaya, Abdulraham I; Tashkandi, Nabiha; Massadeh, Salam; Almuzzaini, Bader; Ehaideb, Salleh N; Bosaeed, Mohammad; Ayoub, Kamal; Yezli, Saber; Khan, Anas; Alaskar, Ahmed; Bouchama, Abderrezak.
Affiliation
  • Alghamdi J; Saudi Biobank, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia. Electronic address: alghamdija@ngha.med.sa.
  • Alaamery M; Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard- Health Affairs, Riyadh, Saudi Arabia; KACST-BWH Centre of Excellence for Biomedicine, Joint Centers
  • Barhoumi T; Core Facility and Research Platforms, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Rashid M; Department of Bioinformatics, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Alajmi H; Saudi Biobank, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Aljasser N; Saudi Biobank, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Alhendi Y; Saudi Biobank, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Alkhalaf H; Saudi Biobank, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Alqahtani H; Saudi Biobank, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Algablan O; Saudi Biobank, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Alshaya AI; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Tashkandi N; Nursing Services, Ministry of the National Guard - Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Massadeh S; Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard- Health Affairs, Riyadh, Saudi Arabia; KACST-BWH Centre of Excellence for Biomedicine, Joint Centers
  • Almuzzaini B; Medical Genomics Research Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Ehaideb SN; Experimental Medicine Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • Bosaeed M; Department of Medicine, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Ayoub K; King Abdulaziz Cardiac Center, Ministry of the National Guard - Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Yezli S; The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
  • Khan A; The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alaskar A; Oncology Department, Ministry of the National Guard - Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Bouchama A; Experimental Medicine Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia. Electronic address: bouchamaab@ngha.med.sa.
Genomics ; 113(4): 1733-1741, 2021 07.
Article in En | MEDLINE | ID: mdl-33838280

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Genetic Predisposition to Disease / SARS-CoV-2 / COVID-19 / Membrane Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Genomics Journal subject: GENETICA Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Genetic Predisposition to Disease / SARS-CoV-2 / COVID-19 / Membrane Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Genomics Journal subject: GENETICA Year: 2021 Type: Article